NetTargets provides the most efficient and promising way of drug discovery based on 20+ years of systems biology research. NetTargets, Inc. is a spinout company based on over-20-year accumulated expertise from KAIST, one of the top research institutes in South Korea. NetTargets was launched in August 2019 on the basis of deep knowledge and experience in systems biology and AI. Our missions are finding novel drug targets and leading first-in-class drug development by its cutting-edge technology of “AI-enhanced systems biology”. NetTargets provides the most efficient and promising way of drug discovery based on systems biology research.